Cleared Traditional

K252282 - SurgiCount+ System (FDA 510(k) Clearance)

Mar 2026
Decision
237d
Days
Class 2
Risk

K252282 is an FDA 510(k) clearance for the SurgiCount+ System. This device is classified as a Image Processing Device For Estimation Of External Blood Loss (Class II - Special Controls, product code PBZ).

Submitted by Stryker Instruments (Portage, US). The FDA issued a Cleared decision on March 16, 2026, 237 days after receiving the submission on July 22, 2025.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 880.2750. An Image Processing Device For Estimation Of External Blood Loss Is A Device To Be Used As An Aid In Estimation Of Patient External Blood Loss. The Device May Include Software And/or Hardware That Is Used To Process Images Capturing Externally Lost Blood To Estimate The Hemoglobin Mass And/or The Blood Volume Present In The Images..

Submission Details

510(k) Number K252282 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2025
Decision Date March 16, 2026
Days to Decision 237 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code PBZ — Image Processing Device For Estimation Of External Blood Loss
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.2750
Definition An Image Processing Device For Estimation Of External Blood Loss Is A Device To Be Used As An Aid In Estimation Of Patient External Blood Loss. The Device May Include Software And/or Hardware That Is Used To Process Images Capturing Externally Lost Blood To Estimate The Hemoglobin Mass And/or The Blood Volume Present In The Images.